ClinicalTrials.gg
CompletedNCT05408468Updated Apr 23, 2026Results posted

Pilot Evaluation of FAMCOPE-ICU (Family Coping and Emotion Regulation Tool in the ICU)

An interventional study of FAMCOPE-ICU in Emotion Regulation and Coping Skills, sponsored by University Hospitals Cleveland Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 89 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-23.

Sponsored by University Hospitals Cleveland Medical Center · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
49
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
All
01

Study summary

Having a family member or loved one in the ICU can be a very stressful experience. The investigators have created a tablet-based tool (FAMCOPE-ICU) that is designed to help people in this position cope with this experience.

02

Conditions studied

  • Emotion Regulation
  • Coping Skills

Keywords

  • Critical Care
  • Informal Caregiving
  • Surrogate Decision-Making
  • Self-Regulation
03

In context

Emotional Regulation

545 studies on the registry are indexed under Emotional Regulation; 188 are open to participants now.

This study's enrollment of 49 is below the median of 79 across 498 interventional studies indexed under Emotional Regulation.

Browse Emotional Regulation studies →

Lead sponsor

University Hospitals Cleveland Medical Center is the lead sponsor of 295 studies on the registry; 45 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 30 (83%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Patient Inclusion Criteria:

  • 18-89 years old
  • Intensive Care Unit (ICU) length of stay (LOS) >= 48 hours
  • No anticipated ICU LOS for next 24 hours
  • Unable to make healthcare decisions

Family Inclusion Criteria

  • Identified by critical care team as legally authorized representative (LAR)
  • Able to speak or comprehend English
  • >= 18 years old

Patient Exclusion Criteria:

  • Less than 18 years or older than 89 years
  • ICU LOS \< 48 hours
  • Anticipated ICU discharge within next 24 hours
  • Able to make healthcare decisions

Family Exclusion Criteria

  • Not identified by critical care team as the LAR
  • Unable to speak or comprehend English
  • \< 18 years old
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
49 participants (actual)

Study arms

  • Experimental
    FAMCOPE-ICU

    A digital eHealth emotion regulation and coping intervention.

    Behavioral: FAMCOPE-ICU

  • No intervention
    Usual Care

    The care and support routinely provided to SDMs of critically ill patients.

Interventions

  • BehavioralFAMCOPE-ICU

    (1) FAMCOPE-ICU is a digital eHealth emotion regulation and coping intervention. FAMCOPE-ICU contains three digital modules representing the three interventional doses. Corresponding with Gross's Extended Process Model of Emotion Regulation, the three respective doses entail assessments, adaptive feedback, and interactive activities pertaining to understanding their affective experiences, learning strategies to regulate emotions and stress, and practicing these skills in a virtual decision-making task. Each dose of the intervention is expected to last 10-15 minutes

06

What researchers measure

Primary outcomes

  1. Acceptability of Intervention Measure

    Four item self-report survey; item responses range from 1 (completely disagree) to 5 (completely agree)

    Time frame: After dose 1, 5 minutes

  2. Acceptability of Intervention Measure

    Four item self-report survey; item responses range from 1 (completely disagree) to 5 (completely agree)

    Time frame: After dose 2, 5 minutes

  3. Acceptability of Intervention Measure

    Four item self-report survey; item responses range from 1 (completely disagree) to 5 (completely agree)

    Time frame: After dose 3, 5 minutes

Secondary outcomes

  1. Change in Anxiety as Measured by PROMIS Anxiety Short Form

    Name: PROMIS Item Bank v1.0-Emotional Distress-Anxiety - Short Form 4a Scoring: The four items' responses (ranging from 1 (Never) to 5 (Always) are summed to form a raw score. The raw scores are converted to a T-Score (mean = 50; Standard deviation = 10) derived from a general population. Interpretation: Higher scores indicate a greater severity in anxiety. Scores less than 55 are "within normal limits", 55-60 are "mild", 60-70 are "moderate", and greater than 70 are "severe".

    Time frame: Baseline (enrollment), one week.

  2. Change in Depression as Measured by PROMIS Depression Short Form

    Name: PROMIS Item Bank v1.0-Emotional Distress-Depression - Short Form 4a Scoring: The four items' responses (ranging from 1 (Never) to 5 (Always) are summed to form a raw score. The raw scores are converted to a T-Score (mean = 50; Standard deviation = 10) derived from a general population. Interpretation: Higher scores indicate greater severity in depression. Scores less than 55 are "within normal limits," 55-60 are "mild," 60-70 are "moderate," and greater than 70 are "severe."

    Time frame: Baseline (enrollment), one week.

  3. Sleep Disturbance as Measured by PROMIS Sleep Disturbance Short Form

    Name: PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 8b Scoring: The eight items' responses (ranging from 1 (Never) to 5 (Always) are summed to form a raw score. The raw scores are converted to a T-Score (mean = 50; Standard deviation = 10) derived from a general population. Interpretation: Higher scores indicate greater severity in anxiety. Scores less than 55 are "within normal limits," 55-60 are "mild," 60-70 are "moderate," and greater than 70 are "severe."

    Time frame: Baseline (enrollment)

  4. Decision Fatigue Scale

    Nine item self-report survey; item responses range from 0 (Strongly Disagree) to 3 (Strongly Agree). Item are summed to form a raw score (range 0-27), with higher scores indicated higher decision fatigue.

    Time frame: One week post-enrollment

  5. Decisional Conflict Scale

    10 item self-report survey; item responses are "yes" (0), "unsure" (2), and "no" (4). Items are summed, divided by 10, multiplied by 25. Scores range from 0 (no decisional conflict) to 100 (high decisional conflict)

    Time frame: One week post-enrollment

  6. Satisfaction as Measured by the Family Satisfaction in the Intensive Care Unit Scale - 24R

    Four item self-report survey; item responses range from 1 (Very dissatisfied) to 5 (Completely satisfied)

    Time frame: One week post-enrollment

07

Results

Posted Mar 28, 2025

Participant flow

Participant flow — Overall Study
MilestoneFAMCOPE-ICUUsual Care
Started2920
Completed1917
Not completed103
Withdrew: Lost to follow-up31
Withdrew: Physician decision10
Withdrew: Overwhelmed by clinical situation30
Withdrew: Personal illness precluding participation10
Withdrew: Withdrawn due to death patient death (unrelated to lar participation in trial)22

Outcome measures

PrimaryAcceptability of Intervention Measure

Four item self-report survey; item responses range from 1 (completely disagree) to 5 (completely agree)

Time frame:
After dose 1, 5 minutes
Reported as:
Mean · units on a scale
Acceptability of Intervention Measure
units on a scaleFAMCOPE-ICUUsual Care
Acceptability of Intervention Measure4.36 ± 0.7—
PrimaryAcceptability of Intervention Measure

Four item self-report survey; item responses range from 1 (completely disagree) to 5 (completely agree)

Time frame:
After dose 2, 5 minutes
Reported as:
Mean · units on a scale
Acceptability of Intervention Measure
units on a scaleFAMCOPE-ICUUsual Care
Acceptability of Intervention Measure4.37 ± 0.69—
PrimaryAcceptability of Intervention Measure

Four item self-report survey; item responses range from 1 (completely disagree) to 5 (completely agree)

Time frame:
After dose 3, 5 minutes
Reported as:
Mean · units on a scale
Acceptability of Intervention Measure
units on a scaleFAMCOPE-ICUUsual Care
Acceptability of Intervention Measure4.27 ± 1—
SecondaryChange in Anxiety as Measured by PROMIS Anxiety Short Form

Name: PROMIS Item Bank v1.0-Emotional Distress-Anxiety - Short Form 4a Scoring: The four items' responses (ranging from 1 (Never) to 5 (Always) are summed to form a raw score. The raw scores are converted to a T-Score (mean = 50; Standard deviation = 10) derived from a general population. Interpretation: Higher scores indicate a greater severity in anxiety. Scores less than 55 are "within normal limits", 55-60 are "mild", 60-70 are "moderate", and greater than 70 are "severe".

Time frame:
Baseline (enrollment), one week.
Reported as:
Least squares mean · T score
Change in Anxiety as Measured by PROMIS Anxiety Short Form
T scoreFAMCOPE-ICUUsual Care
Baseline64.989 (61.521 to 68.457)61.30 (57.197 to 64.403)
One week59.394 (55.616 to 63.172)57.518 (53.275 to 61.761)
Statistical analysis
  • FAMCOPE-ICU · Mixed Models Analysis · p = 0.387 · Mean difference (net): -5.595Baseline 1.731 One week 1.894
  • Usual Care · Mixed Models Analysis · p = 0.387 · Mean difference (net): -3.782Baseline 2.048 One week 2.122
SecondaryChange in Depression as Measured by PROMIS Depression Short Form

Name: PROMIS Item Bank v1.0-Emotional Distress-Depression - Short Form 4a Scoring: The four items' responses (ranging from 1 (Never) to 5 (Always) are summed to form a raw score. The raw scores are converted to a T-Score (mean = 50; Standard deviation = 10) derived from a general population. Interpretation: Higher scores indicate greater severity in depression. Scores less than 55 are "within normal limits," 55-60 are "mild," 60-70 are "moderate," and greater than 70 are "severe."

Time frame:
Baseline (enrollment), one week.
Reported as:
Least squares mean · T Score
Change in Depression as Measured by PROMIS Depression Short Form
T ScoreFAMCOPE-ICUUsual Care
Change in Depression as Measured by PROMIS Depression Short Form56.896 (53.504 to 60.288)53.905 (49.892 to 57.918)
Statistical analysis
  • FAMCOPE-ICU · Mixed Models Analysis · p = 0.062 · Mean difference (net): -4.50Baseline 1.693 One week 1.840
  • Usual Care · Mixed Models Analysis · p = 0.062 · Mean difference (net): -0.764Baseline 2.003 One week 2.069
SecondarySleep Disturbance as Measured by PROMIS Sleep Disturbance Short Form

Name: PROMIS Item Bank v1.0 - Sleep Disturbance - Short Form 8b Scoring: The eight items' responses (ranging from 1 (Never) to 5 (Always) are summed to form a raw score. The raw scores are converted to a T-Score (mean = 50; Standard deviation = 10) derived from a general population. Interpretation: Higher scores indicate greater severity in anxiety. Scores less than 55 are "within normal limits," 55-60 are "mild," 60-70 are "moderate," and greater than 70 are "severe."

Time frame:
Baseline (enrollment)
Reported as:
Mean · T-Score
Sleep Disturbance as Measured by PROMIS Sleep Disturbance Short Form
T-ScoreFAMCOPE-ICUUsual Care
Sleep Disturbance as Measured by PROMIS Sleep Disturbance Short Form60.63 ± 8.7255.87 ± 8.88
SecondaryDecision Fatigue Scale

Nine item self-report survey; item responses range from 0 (Strongly Disagree) to 3 (Strongly Agree). Item are summed to form a raw score (range 0-27), with higher scores indicated higher decision fatigue.

Time frame:
One week post-enrollment
Reported as:
Mean · Raw score
Decision Fatigue Scale
Raw scoreFAMCOPE-ICUUsual Care
Decision Fatigue Scale14.47 ± 10.0811.88 ± 5.98
Statistical analysis
  • FAMCOPE-ICU vs Usual Care · t-test, 2 sided · p = 0.369 · Median difference (final values): 2.58
SecondaryDecisional Conflict Scale

10 item self-report survey; item responses are "yes" (0), "unsure" (2), and "no" (4). Items are summed, divided by 10, multiplied by 25. Scores range from 0 (no decisional conflict) to 100 (high decisional conflict)

Time frame:
One week post-enrollment
Reported as:
Mean · Raw score
Decisional Conflict Scale
Raw scoreFAMCOPE-ICUUsual Care
Decisional Conflict Scale7.89 ± 13.985.29 ± 7.39
Statistical analysis
  • FAMCOPE-ICU vs Usual Care · t-test, 2 sided · p = 0.498 · Median difference (final values): 2.59
SecondarySatisfaction as Measured by the Family Satisfaction in the Intensive Care Unit Scale - 24R

Four item self-report survey; item responses range from 1 (Very dissatisfied) to 5 (Completely satisfied)

Time frame:
One week post-enrollment

No measurements were reported for this outcome.

Adverse events

Collected over One week post enrollment. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
FAMCOPE-ICU0/29 (0%)0/29 (0%)0/29 (0%)
Usual Care0/20 (0%)0/20 (0%)0/20 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)FAMCOPE-ICUUsual CareTotal
Mean58.07 ± 13.8459.20 ± 12.6458.54 ± 13.23
Sex: Female, Male
Sex: Female, Male(Participants)FAMCOPE-ICUUsual CareTotal
Female201636
Male8412
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)FAMCOPE-ICUUsual CareTotal
Hispanic or Latino101
Not Hispanic or Latino272047
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)FAMCOPE-ICUUsual CareTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American347
White251641
More than one race000
Unknown or Not Reported000
08

Study locations

1 site
  • University Hospitals Cleveland Medical Center
    Cleveland, Ohio 44106, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05408468
Responsible party
Sponsor
First posted
Jun 7, 2022
Start date
Aug 15, 2022
Primary completion
Jul 27, 2023
Completion
Jul 27, 2023
Results posted
Mar 28, 2025
Last update
Apr 23, 2026

Study contacts

Seth A Hoffer, MD
principal investigator · University Hospitals Cleveland Medical Center
Grant A Pignatiello, PhD, RN
principal investigator · Case Western Reserve University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion